Management tracks: Neurogene, HomoShear, Hookipa, Passage Bio, Artios, EMD Serono, Novartis, Illumina, Precision and CureDuchenne

Neurogene Inc. hired Christine Mikail as president. She is a co-founder of neurology specialty pharma Neumentum Inc. and biotech consulting firm Ferndale Advisors. Neurogene is developing disease-modifying gene therapies for two monogenic, pediatric disorders in which enzyme replacement is not feasible or hasn’t been explored (see “Genes Over ERT for Monogenic CNS Diseases”).

HemoShear Therapeutics LLC, which is focused on metabolic disorders, hired Brian Johns as CSO. Johns was VP, external discovery sciences at ViiV Healthcare Ltd., which is majority owned by GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). While at GSK, he co-discovered the HIV antiviral Tivicay dolutegravir. ...